Terry L. Wahls
7
2
4
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
1 terminated/withdrawn out of 7 trials
66.7%
-19.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Autoimmune Intervention Mastery Course Study
Role: lead
Creating Health Course Study for People With Rheumatological Conditions
Role: lead
Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
Role: lead
Efficacy of Diet on Quality of Life in Multiple Sclerosis
Role: lead
Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study
Role: lead
Dietary Approach to Improving Quality of Life in Amyotrophic Lateral Sclerosis
Role: lead
Wahls Paleo Diet and Progressive Multiple Sclerosis
Role: lead
All 7 trials loaded